BioLife Solutions, Inc. Deferred Revenue (Non-Current)
BioLife Solutions, Inc. (BLFS) had Deferred Revenue (Non-Current) of $64.00 thousand as of 2021-03-31, per its 10-Q filed 2021-05-17.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredRevenueNoncurrent · last filed 2021-05-17
- 2021-03-31: Deferred Revenue, Noncurrent $64.00K.
- 2020-12-31: Deferred Revenue, Noncurrent $71.00K.
- 2019-12-31: Deferred Revenue, Noncurrent $0.00.
- 2013-12-31: Deferred Revenue, Noncurrent $0.00.
| Period end | Deferred Revenue, Noncurrent |
|---|---|
| 2021-03-31 | $64.00K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $71.00K 10-Q · filed 2021-05-17 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-31 |
| 2013-12-31 | $0.00 10-K · filed 2014-02-12 |
| 2013-06-30 | $0.00 10-Q · filed 2013-08-12 |
| 2012-12-31 | $89.17K 10-K · filed 2014-02-12 |
| 2012-09-30 | $94.17K 10-Q · filed 2012-11-13 |
| 2012-06-30 | $99.17K 10-Q · filed 2012-08-14 |
| 2012-03-31 | $104.17K 10-Q · filed 2012-05-14 |
| 2011-12-31 | $109.17K 10-K · filed 2013-03-29 |
| 2011-09-30 | $114.17K 10-Q · filed 2011-11-14 |
| 2011-06-30 | $119.17K 10-Q · filed 2011-08-12 |
| 2010-12-31 | $129.17K 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |